Bivision is accelerating the development of an integrated, image-guided next-generation targeted radionuclide therapy to improve patients' lives. Unlike conventional drugs and radiopharmaceuticals, our focus is to bring integrated visualization and therapy to the market to enhance cancer patients' treatment outcomes.
The concept of "integrated visualization and therapy" combines a pair of closely related diagnostic and therapeutic drugs and achieves a "see and treat" approach using medical imaging devices. The molecular structures of the diagnostic and therapeutic drugs have the identical structure, only the differences primarily are in the chelated radioactive isotopes. This integrated visualization and therapy approach maximizes the benefits of personalized treatment.